Institute of Genomics and Integrative Biology (IGIB), constituent lab of CSIR, has signed a MoU with TATA Sons for licensing of KNOWHOW for FELUDA in order to execute rapid diagnosis of COVID-19. The MoU aims to provide license which will enable transfer of the knowledge for scaling up the KNOWHOW in the form of a kit in order to employ it for COVID-19 testing on ground as soon as possible. Hence, as per MoU, CSIR-IGIB will now work along with TATA Sons to bring FELUDA for widespread use at the earliest.
Click Here To Get Test Series For SBI PO 2020
FNCAS9 Editor Linked Uniform Detection Assay (FELUDA) has been designed to alleviate the current COVID-19 situation and cater to mass testing. The main advantages of FELUDA is its affordability, relative ease of use as well as non-dependency on expensive Q-PCR machines.
The World Health Organization (WHO) has honored the individuals, government agencies, researchers and organizations from…
On 31st May 2026 Veteran playback singer Suman Kalyanpur passed away in Mumbai. She was…
Indian Badminton duo Satwiksairaj Rankireddy and Chirag Shetty have won the Singapore Open 2026 men's…
June is the sixth month of the year and consists of 30 days. The month…
The recent forest fire incident in Kasauli, Himachal Pradesh highlighted the critical role of aerial…
General NS Raja Subramani officially took charge as the India's next Chief of Defense Staff…